APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,570,215 | -56.0% | 41,278 | +5.5% | 0.00% | -55.6% |
| Q2 2023 | $3,565,107 | -11.2% | 39,134 | -35.7% | 0.01% | -10.0% |
| Q1 2023 | $4,014,919 | +196613.3% | 60,869 | +54.2% | 0.01% | +100.0% |
| Q4 2022 | $2,041 | -99.9% | 39,477 | +23.6% | 0.01% | -16.7% |
| Q3 2022 | $2,182,000 | +24.5% | 31,944 | -17.6% | 0.01% | +20.0% |
| Q2 2022 | $1,753,000 | -36.4% | 38,772 | -28.6% | 0.01% | -28.6% |
| Q1 2022 | $2,757,000 | +9.9% | 54,266 | +2.2% | 0.01% | +16.7% |
| Q4 2021 | $2,509,000 | +147.9% | 53,075 | +72.9% | 0.01% | +100.0% |
| Q3 2021 | $1,012,000 | -46.9% | 30,698 | +1.8% | 0.00% | -40.0% |
| Q2 2021 | $1,906,000 | +16.1% | 30,156 | -21.2% | 0.01% | 0.0% |
| Q1 2021 | $1,642,000 | +71.0% | 38,277 | +128.2% | 0.01% | +66.7% |
| Q4 2020 | $960,000 | +46.1% | 16,777 | -23.0% | 0.00% | +50.0% |
| Q3 2020 | $657,000 | -7.3% | 21,778 | +0.3% | 0.00% | -33.3% |
| Q2 2020 | $709,000 | +30.8% | 21,703 | +7.2% | 0.00% | +50.0% |
| Q1 2020 | $542,000 | -28.1% | 20,248 | -17.8% | 0.00% | -33.3% |
| Q4 2019 | $754,000 | -47.9% | 24,623 | -59.0% | 0.00% | -50.0% |
| Q3 2019 | $1,447,000 | -12.5% | 60,082 | -7.9% | 0.01% | 0.0% |
| Q2 2019 | $1,653,000 | – | 65,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |